Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Arcus Biosciences, Inc. | 10%+ Owner | Common Stock | 30.1M | $631M | $21.00 | Jan 29, 2024 | Direct |
Arcellx, Inc. | 10%+ Owner | Common Stock | 6.72M | $371M | $55.27 | Dec 28, 2023 | Direct |
ASSEMBLY BIOSCIENCES, INC. | 10%+ Owner | Common Stock | 1.27M | $19M | $14.93 | Jun 17, 2024 | Direct |
LEAP THERAPEUTICS, INC. | 10%+ Owner | Common Stock | 5.32M | $15.2M | $2.85 | Apr 10, 2024 | Direct |
HOOKIPA Pharma Inc. | 10%+ Owner | Common Stock | 18.8M | $13.6M | $0.73 | Dec 20, 2023 | Direct |
Allovir, Inc. | 10%+ Owner | Common Stock | 16.6M | $11.2M | $0.67 | Jun 27, 2023 | Direct |
Xilio Therapeutics, Inc. | 10%+ Owner | Common Stock | 7.35M | $5.58M | $0.76 | Apr 2, 2024 | Direct |
Xilio Therapeutics, Inc. | 10%+ Owner | Prefunded Warrants (right to buy) | 3.88M | $2.95M | $0.76 | Apr 2, 2024 | Direct |
Kyverna Therapeutics, Inc. | 10%+ Owner | Common Stock | 4.13M | Feb 12, 2024 | Direct | ||
ASSEMBLY BIOSCIENCES, INC. | 10%+ Owner | Warrant to purchase Common Stock | 180K | Jun 17, 2024 | Direct | ||
Kyverna Therapeutics, Inc. | 10%+ Owner | Series A-2 Convertible Preferred Stock | 0 | Feb 12, 2024 | Direct | ||
Kyverna Therapeutics, Inc. | 10%+ Owner | Series B Convertible Preferred Stock | 0 | Feb 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ASMB | ASSEMBLY BIOSCIENCES, INC. | Jun 17, 2024 | 2 | $0 | 4 | Jun 20, 2024 | 10%+ Owner |
LPTX | LEAP THERAPEUTICS, INC. | Apr 10, 2024 | 0 | $0 | 3 | Apr 19, 2024 | 10%+ Owner |
XLO | Xilio Therapeutics, Inc. | Apr 2, 2024 | 2 | $3.32M | 4 | Apr 3, 2024 | 10%+ Owner |
XLO | Xilio Therapeutics, Inc. | Mar 27, 2024 | 0 | $0 | 3 | Apr 3, 2024 | 10%+ Owner |
KYTX | Kyverna Therapeutics, Inc. | Feb 12, 2024 | 4 | $20M | 4 | Feb 13, 2024 | 10%+ Owner |
KYTX | Kyverna Therapeutics, Inc. | Feb 7, 2024 | 0 | $0 | 3 | Feb 7, 2024 | 10%+ Owner |
RCUS | Arcus Biosciences, Inc. | Jan 29, 2024 | 1 | $320M | 4 | Jan 31, 2024 | 10%+ Owner |
ACLX | Arcellx, Inc. | Dec 28, 2023 | 0 | $0 | 3 | Dec 28, 2023 | 10%+ Owner |
HOOK | HOOKIPA Pharma Inc. | Dec 20, 2023 | 0 | $0 | 3 | Dec 22, 2023 | 10%+ Owner |
ASMB | ASSEMBLY BIOSCIENCES, INC. | Oct 16, 2023 | 0 | $0 | 3 | Oct 25, 2023 | 10%+ Owner |
RCUS | Arcus Biosciences, Inc. | Jun 28, 2023 | 1 | $19.5M | 4 | Jun 30, 2023 | 10%+ Owner |
ALVR | Allovir, Inc. | Jun 27, 2023 | 1 | $11M | 4 | Jun 28, 2023 | 10%+ Owner |
ALVR | Allovir, Inc. | Jul 28, 2022 | 0 | $0 | 3 | Aug 5, 2022 | 10%+ Owner |
HOOK | HOOKIPA Pharma Inc. | Feb 15, 2022 | 0 | $0 | 3 | Feb 17, 2022 | 10%+ Owner |